Calendar of Events

North Central


Trends in Transfusion Practices

7:30 AM - 4:30 PM
1890 Buford Avenue, Room 135
St. Paul, MN


Expert Speakers and Exceptional Topics

Relevant topics lead this year’s conference, including:

  • How to best handle rare blood needs over an extended period of time.
  • New topics from AABB.
  • Changes in health care lead by an industry panel.
  • Implications of weak D led by a national Immunohematology Reference Lab (IRL) expert.
  • A living proof story from a physician’s perspective on a massive transfusion event.
  • Patient consent/patient rights.
  • The surprisingly evolving world of fecal matter transplant.


This intermediate-level seminar is designed for nurses and laboratory professionals with an interest in the newest developments in transfusion medicine and blood banking. The program will provide an update on new technologies and practical issues regarding transfusion therapies.

Program Objectives

At the conclusion of this program, participants will be able to:

  • Be conversant in what is detected by serologic methods and understand what D antigens their facility’s testing detects.
  • Describe mitigation strategies to prevent allergic reactions and the role of plasma removal, explain the risk and benefits of using Group A plasma for emergent transfusion to patients, and discuss the impact of the age of transfused RBC units on clinical outcomes in premature infants.
  • Discuss changes in health care from a rural and system prospective, as well as long-term implications for the health care industry.
  • Discover how one physician’s experience in a rural hospital reinforced the need for an MTP in all medical facilities.
  • Review strategies for best practice use of plasma through good blood management.
  • Recognize how to avoid the Seven Deadly Sins of mental mistakes, control illogical thinking and clearly direct your thinking style to achieve results.
  • Examine current uses and indications for plasma transfusion and gain knowledge to consider future requests for alternative plasma products that are newly available or are expected to be approved soon.
  • Explain what should be included when obtaining meaningful informed consent, review alternatives to RBC transfusion, and emphasize a patient's right to refuse.
  • Discuss what blood types are most difficult to find in the USA and how to source rare types for patients.
  • Describe the clinical presentation, diagnostic criteria and management of dengue in a patient. Recognize that dengue is a transfusion transmissible entity and evaluate the issues involved in testing for dengue and how that applies to donor screening.
  • Identify the common infectious disease tests between both blood donors and fecal microbiota (FM) donors. Compile a list of other clinical conditions, which are supported by evidence that fecal microbiota transplant (FMT may be a beneficial treatment). Explain the indications for treatment and the process of collection, testing, and administration of FM.
  • Describe two situations in which adsorption and elution techniques would be useful.
  • Outline the challenges facing the IRL when a patient needs rare RBCs for an extended period of time, describe the role of good coordination between facilities handling the products, and explain how to troubleshoot unexpected problems that may arise when trying to obtain rare RBCs.

For more information about this conference including program fees and scheduled presenters, contact Jan Ehrhart at 651-291-6778 or